Adalimumab vs Donepezil

## Adalimumab vs Donepezil: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Donepezil**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Donepezil**: Reversible acetylcholinesterase inhibitor.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Donepezil — 70 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Donepezil — C24H29NO3.

**Molecular Weight**: Adalimumab — N/A; Donepezil — 379.4920 g/mol.

**Type**: Adalimumab — Antibody; Donepezil — Small molecule.